BioengineeringbioRxivPreprint
Antigen-specific T cell immunotherapy by in vivo mRNA delivery
Fang‐Yi Su, Jamison C. Siebart, Ching Shen Chan…·Gabriel A. Kwong
This paper develops antigen-presenting nanoparticles (APNs) for in vivo mRNA delivery to engineer Ag-specific T cells, showing efficacy in mouse models of type 1 diabetes and multiple myeloma.
4 citations